Skip to content
Hemispherx Biopharma, Inc. Logo
  • COMPANY
  • PRODUCTS
  • R & D
    • Product Candidates Overview
    • Pipeline
    • Orphan Drug Designations
  • PARTNERING
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • XBRL Filings
    • Stockholder Meeting
    • Corporate Governance
    • Email Alerts
    • Investor Contact
  • BLOG
  • CONTACT

Press Releases

 
Feb 11, 2020
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus

Feb 05, 2020
AIM ImmunoTech Announces Completion of Third-Party Clinical Trial Using Ampligen in Combination with Other Therapies as Adjuvant Treatment of Peritoneal Surface Malignancies

Dec 11, 2019
AIM ImmunoTech to Present at the Investor Summit in Philadelphia

Dec 04, 2019
AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020

Nov 15, 2019
CORRECTION: AIM ImmunoTech Provides Business Update for the Third Quarter of 2019

Nov 15, 2019
AIM ImmunoTech Provides Business Update for the Third Quarter of 2019

Oct 23, 2019
AIM ImmunoTech to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

Oct 07, 2019
AIM ImmunoTech Provides Comprehensive Clinical Trials Update With Major Inflection Points Identified

Sep 25, 2019
AIM ImmunoTech, Inc. Announces Pricing of $8 Million Public Offering

Sep 24, 2019
AIM ImmunoTech Inc. Announces a Second DoD Award, This One of $8.3 Million, to Fund Phase 2 Clinical Trial to Study Ampligen as Part of a New Treatment for Brain-Metastatic Breast Cancer at the Moffitt Cancer Center

 5   6   7   8   9     10    11   12   13   14   15 
 <<   <   >   >> 
Hemispherx Biopharma, Inc. Logo White

Latest News

  • CEO Roadshow Interviews Hemispherx Thomas K. Equels
  • Introducing You to the First Ampligen Quarterly Update
  • Proactive Investors USA Sits Down with Hemispherx CEO Thomas K. Equels

Privacy / Terms of Use

  • Terms Of Use
  • Investor Contact

Tweets by AIM Immuno

© Copyright | All Rights Reserved | AIM ImmunoTech Inc. | Privacy Policy | Terms of Use
FacebookTwitterYouTubeLinkedIn

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window